Appili Therapeutics Ati-1701 Biodefense Vaccine Secures ~Us$14 Million Of Funding From The U.S. Department Of Defense In Partnership With The U.S. Air Force Academy
Amount Raised
$14 Million
Round Type
Funding Round
Description
Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that the U.S. Department of Defense (“DOD”), via the Joint Science and Technology Office of the Defense Threat Reduction Agency (“DTRA”) in partnership with the U.S. Air Force Academy (“USAFA”), will provide at least US$14 million in funding over two years to fund the development of ATI-1701
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Appili Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.
- Aspen Neuroscience raised $40M (Debt Financing) on December 22, 2022.
- Cardurion Pharmaceuticals raised $18M on December 16, 2022.
- Hemispherian AS raised an undisclosed amount (Series A) on November 24, 2022.
- Trait Biosciences Inc. raised $230K (Series A) on November 16, 2022.
- Hemispherian AS raised $9.8M (Funding Round) on October 19, 2022.
- Viome raised $67M (Series C) on October 18, 2022.
Who to call at Appili Therapeutics Inc., and when
A new round usually means Appili Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Appili Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Appili Therapeutics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Appili Therapeutics Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Appili Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Appili Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.